TVRD Stock Analysis: Buy, Sell, or Hold?
TVRD - Tvardi Therapeutics, Inc. Common Stock
$4.22
0.01 (0.24%)
▲
5d:
+34.39%
30d:
+42.57%
90d:
+13.44%
WAIT
LOW Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 12, 2026
3d
Get Alerted When TVRD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TVRD is 17.9% above its trading range ($3.58). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TVRD is 17.9% above its trading range ($3.58). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TVRD is currently trading at $4.22, which is considered extended relative to its 30-day fair value range of $2.91 to $3.58.
Technical Outlook: Technically, TVRD is in a strong downtrend. The price is approaching resistance at $3.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TVRD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.17 (+94.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TVRD is in a strong downtrend. The price is approaching resistance at $3.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TVRD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.17 (+94.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.91 -
$3.58
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+17.9% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 94.0% below Wall St target ($8.17)
- WARNING: Recommendation downgraded due to 17.9% overvaluation
Trading Range Analysis
30-Day Trading Range
$2.91 -
$3.58
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.94
Resistance Level
$3.79
Current Trend
Strong Downtrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.72
Wall Street Target
$8.17
(+94.0%)
Share & Embed Analysis
Last updated: May 08, 2026 12:07 PM ET
Data refreshes hourly during market hours. Next update: 1:06 PM
Data refreshes hourly during market hours. Next update: 1:06 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVRD showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 52 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 56 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 55 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 43 HOLD |